Therefore, if FcRn expression were to be modulated throughout oncogenic processes, for example, through a crosstalk between cancer stem cells and tumor infiltrating cells, it could hamper cancer immunosurveillance by decreasing cross‐presentation and thus antibody‐ and cell‐dependent‐cytotoxicity. The gene discussed is FCGRT; the disease is neoplasm.